Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
This study has been completed.
Sponsor:
Helsinn Therapeutics (U.S.), Inc
Information provided by:
Helsinn Therapeutics (U.S.), Inc
ClinicalTrials.gov Identifier:
NCT00622193
First received: February 12, 2008
Last updated: June 8, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | June 8, 2011 |